PLN-101095

N/A

Report date: 2025/04/10 15:20:17
NME

Base Information

Drug NamePLN-101095
Drug Alias NamePLN-101095
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionintegrin alpha V/beta 8 inhibitorsIntegrin alpha-V/beta-1 inhibitors
Targetsintegrin alpha V/beta 8Integrin alpha-V/beta-1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPliant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPliant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A